Gentherm Inc has received FDA 510(k) clearance for its ThermAffyx™ Patient Safety System, a Class II medical device that integrates active patient warming and securement in one platform. Designed specifically for robotic-assisted surgeries, this system addresses challenges like patient hypothermia and movement during procedures, especially in Trendelenburg position. Trials will start in August 2026, with commercial sales expected in Q3 2026, marking a significant expansion in Gentherm's medical product line focused on patient temperature management.
Cardano (ADA) surged 11% in 24 hours, trading between $0.24 and $0.27, driven by a short squeeze as open interest dropped 11.68%. The token now faces immediate resistance at $0.28 and strong resistance at $0.29, with technical indicators showing over...
XRP is approaching a critical resistance level at $1.53, with analyst Ali Martinez noting that a four-hour close above this price could confirm a move toward $1.62, representing about 7% upside. Despite previous attempts to break above $1.50, XRP has...
Bitcoin has risen nearly 47% from its July low of $57,800 to around $86,000, yet Binance Research warns the current cycle bottom remains unconfirmed based on historical patterns. Their study found that rebounds of this size often fail if they occur b...
Metaplanet plans to allocate 85% to 90% of its total assets to Bitcoin, with the remaining 10% to 15% directed towards mergers, acquisitions, income-generating assets, and asset management. The company aims to keep borrowing related to its Bitcoin ho...
Alliance Resource Partners (ARLP) is rated Buy with a 12-month target price of $28-29, implying about a 25% total return including a 9.8% yield. The company has fully contracted coal sales for 2026 and most of 2027 priced, ensuring strong cash flow v...
